Intercontinental Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Intercontinental Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$727K	Sell	11,371 -151	-1%	-$10.1K	0.17%	134
2023 Q1	$799K	Sell	11,522 -388	-3%	-$27.4K	0.2%	118
2022 Q4	$857K	Buy	11,910 +261	+2%	+$19.7K	0.25%	94
2022 Q3	$828K	Sell	11,649 -177	-1%	-$12.8K	0.26%	90
2022 Q2	$911K	Hold	11,826	–	–	0.25%	92
2022 Q1	$864K	Sell	11,826 -1,426	-11%	-$95.7K	0.2%	101
2021 Q4	$826K	Buy	13,252 +792	+6%	+$46.5K	0.17%	117
2021 Q3	$737K	Buy	12,460 +29	+0.2%	+$1.91K	0.17%	113
2021 Q2	$831K	Buy	12,431 +292	+2%	+$19K	0.16%	104
2021 Q1	$766K	Buy	12,139 +35	+0.3%	+$2.18K	0.17%	109
2020 Q4	$751K	Sell	12,104 -180	-1%	-$11.1K	0.18%	104
2020 Q3	$741K	Sell	12,284 -482	-4%	-$29K	0.22%	91
2020 Q2	$751K	Sell	12,766 -221	-2%	-$13.2K	0.24%	88
2020 Q1	$724K	Buy	12,987 +627	+5%	+$38.3K	0.38%	68
2019 Q4	$811K	Sell	12,360 -2,796	-18%	-$160K	0.68%	29
2019 Q3	$769K	Sell	15,156 -170	-1%	-$7.99K	0.47%	42
2019 Q2	$695K	Sell	15,326 -937	-6%	-$43.6K	0.36%	45
2019 Q1	$776K	Sell	16,263 -348	-2%	-$17.3K	0.38%	43
2018 Q4	$863K	Sell	16,611 -2,318	-12%	-$125K	0.48%	41
2018 Q3	$1.18M	Hold	18,929	–	–	0.59%	36
2018 Q2	$1.05M	Sell	18,929 -269	-1%	-$14.5K	0.58%	36
2018 Q1	$1.21M	Buy	19,198 +405	+2%	+$26.1K	0.7%	34
2017 Q4	$1.15M	Buy	18,793 +104	+0.6%	+$6.5K	0.65%	33
2017 Q3	$1.19M	Sell	18,689 -21	-0.1%	-$1.23K	0.73%	33
2017 Q2	$1.04M	Buy	18,710 +6,114	+49%	+$333K	0.67%	35
2017 Q1	$685K	Hold	12,596	–	–	0.41%	52
2016 Q4	$736K	Sell	12,596 -75	-0.6%	-$4.1K	0.47%	46
2016 Q3	$683K	Buy	12,671 +800	+7%	+$51.4K	0.49%	48
2016 Q2	$873K	Sell	11,871 -1,820	-13%	-$129K	0.64%	37
2016 Q1	$875K	Sell	13,691 -847	-6%	-$53.4K	0.66%	34
2015 Q4	$1M	Buy	+14,538	New	+$961K	0.69%	36

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Intercontinental Wealth Advisors's BMY Position: Q2 2023 in Review

Intercontinental Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2023, selling an estimated $10.1K and leaving 11,371 shares worth $727K. The position accounts for 0.17% of the portfolio, ranked #134.

Intercontinental Wealth Advisors first reported a position in BMY in Q4 2015 and has held it in 31 quarters since. The position peaked at $1.21M in Q1 2018. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Intercontinental Wealth Advisors held 11,371 shares of Bristol-Myers Squibb worth $727K as of Q2 2023.
Intercontinental Wealth Advisors sold 151 Bristol-Myers Squibb shares in Q2 2023, an estimated $10.1K.
Bristol-Myers Squibb made up 0.17% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #134 holding.
Intercontinental Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 31 quarters since.
Intercontinental Wealth Advisors's Bristol-Myers Squibb position peaked at $1.21M in Q1 2018.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.